In a conference call with investment analysts last year, CSL CEO Paul McKenzie said sales of Hemgenix have progressed slower than expected. "We had 12 [patients on the therapy] in 2024," McKenzie ...
PolyNovo (ASX:PNV) has announced that its chief executive officer, Swami Raote, will officially leave the company in June but ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback